001@ $022,40,105
001A $02000:09-11-92
001B $01999:30-05-09$t21:31:32.000
001D $09999:99-99-99
001U $0utf8
001X $00
002@ $0Aan
003@ $0014668114
003O $aOCoLC$046068686
006G $0921167687
007G $cGBV$0014668114
011@ $a1991
013@ $0ho
019@ $aXA-DE
021A $a@Autonome Neuropathie$dWirkung von Noradrenalin und Tyramin bei Typ-I- und Typ-II-Diabetikern, terminal niereninsuffizienten Patienten und Normalpersonen$hPia Kark
028A $dPia$aKark
034D $a 3 , 162 S
034I $a21 cm
034M $agraph. Darst
037C $b@Würzburg$aUniv., Diss.$c1992
045E $a33
101@ $a22$cPICA
201B/01 $030-04-99$t23:24:55.169
201C/01 $009-12-92
201D/01 $009-12-92
201U/01 $0utf8
203@/01 $008886703X
206X/01 $01107773
208@/01 $a09-12-92$bzu
209A/01 $fSUB$a92 U 5575$du$x00
209G/01 $a9255055757$x00
101@ $a40$cPICA
101B $019-01-98$t07:40:12.872
101C $009-11-92$bD_
101D $009-11-92$bSG
101U $0utf8
107F $04H72/57W
150K $aOK=2
150K/01 $n4$aKark, Pia$bNeuropathie
150K/01 $n12$cKark, Pia
201B/01 $001-11-04$t22:00:26.000
201C/01 $009-11-92$bD_
201D/01 $001-11-04$br40lbs1$a0007
203@/01 $0015458601
208@/01 $a09-11-92$bn
209A/01 $aDISS 92 A 11211$du$x00
209G/01 $a7$$$200468367$x00
201U/01 $0utf8
101@ $a105$cPICA
101B $023-11-00$t09:15:46.107
101C $023-11-00
101D $023-11-00$b6760$a0000
101U $0utf8
107F $0LU00371133
201B/01 $023-11-00$t09:15:46.163
201C/01 $023-11-00
201D/01 $023-11-00$b6760$a0000
203@/01 $0413410102
208@/01 $a23-11-00$bz
209A/01 $fMag$a1992 Ua 2633$du$x00
209C/01 $a1992 Ua 2633$x00
201U/01 $0utf8